Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of APIs and pharmaceutical intermediates in China and internationally. The company offers penicillin, carbapenem, and other products. It also provides contract research, development, and manufacturing services. The company was formerly known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd and changed its name to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012. Jiangxi Fushine Pharmaceutical Co., Ltd. was founded in 2002 and is based in Jingdezhen, China.

Company Data

Name Jiangxi Fushine Pharmaceutical Co., Ltd.

Company Jiangxi Fushine Pharmaceutical Co., Ltd.

Website https://www.fushine.cn

Primary Exchange

SHENZHEN STOCK EXCHANGE

ISIN CNE1000024Z7

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Jian Hua Bao

Market Capitalization 6 Mrd.

Country China

Currency CNY

Employees 2,0 T

Address No. 2, Yuli Industrial Zone, 333000 Jingdezhen

IPO Date 2015-12-22

Ticker Symbols

Name	Symbol
SHENZHEN STOCK EXCHANGE	300497.SZ

More Shares

Investors who hold Jiangxi Fushine Pharmaceutical Co., Ltd. also have the following shares in their portfolio:

BNPPESUSWLDETF U.ETFEOA ETF

ENDESA ADR/ 1/2 ,20 Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog